ES2347754B8 - ORAL SUSPENSION OF IBUPROPHENE LISINATE - Google Patents

ORAL SUSPENSION OF IBUPROPHENE LISINATE Download PDF

Info

Publication number
ES2347754B8
ES2347754B8 ES200901093A ES200901093A ES2347754B8 ES 2347754 B8 ES2347754 B8 ES 2347754B8 ES 200901093 A ES200901093 A ES 200901093A ES 200901093 A ES200901093 A ES 200901093A ES 2347754 B8 ES2347754 B8 ES 2347754B8
Authority
ES
Spain
Prior art keywords
oral suspension
ibuprophene
lisinate
ibuprofen
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200901093A
Other languages
Spanish (es)
Other versions
ES2347754B1 (en
ES2347754A1 (en
Inventor
Maite Tarre Perez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio de Aplicaciones Farmacodinamicas SA
Original Assignee
Laboratorio de Aplicaciones Farmacodinamicas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200901093A priority Critical patent/ES2347754B8/en
Application filed by Laboratorio de Aplicaciones Farmacodinamicas SA filed Critical Laboratorio de Aplicaciones Farmacodinamicas SA
Priority to CN2010800226440A priority patent/CN102448499A/en
Priority to JP2012507789A priority patent/JP5977672B2/en
Priority to PCT/ES2010/000185 priority patent/WO2010125212A1/en
Priority to US13/266,730 priority patent/US20120101159A1/en
Priority to TW099113307A priority patent/TW201038296A/en
Publication of ES2347754A1 publication Critical patent/ES2347754A1/en
Publication of ES2347754B1 publication Critical patent/ES2347754B1/en
Application granted granted Critical
Publication of ES2347754B8 publication Critical patent/ES2347754B8/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Suspensión oral de lisinato de ibuprofeno.#La presente invención se refiere a una composición farmacéutica a base de lisinato de ibuprofeno en forma de suspensión oral y al procedimiento de preparación de la misma.Oral suspension of ibuprofen lysinate. # The present invention relates to a pharmaceutical composition based on ibuprofen lysate in the form of an oral suspension and to the process for preparing it.

ES200901093A 2009-04-27 2009-04-27 ORAL SUSPENSION OF IBUPROPHENE LISINATE Expired - Fee Related ES2347754B8 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES200901093A ES2347754B8 (en) 2009-04-27 2009-04-27 ORAL SUSPENSION OF IBUPROPHENE LISINATE
JP2012507789A JP5977672B2 (en) 2009-04-27 2010-04-27 Suspension for oral administration of ibuprofen ricinate
PCT/ES2010/000185 WO2010125212A1 (en) 2009-04-27 2010-04-27 Oral ibuprofen lysinate suspension
US13/266,730 US20120101159A1 (en) 2009-04-27 2010-04-27 Ibuprofen lysinate oral suspension
CN2010800226440A CN102448499A (en) 2009-04-27 2010-04-27 Oral ibuprofen lysinate suspension
TW099113307A TW201038296A (en) 2009-04-27 2010-04-27 Ibuprofen lysinate oral suspension

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200901093A ES2347754B8 (en) 2009-04-27 2009-04-27 ORAL SUSPENSION OF IBUPROPHENE LISINATE

Publications (3)

Publication Number Publication Date
ES2347754A1 ES2347754A1 (en) 2010-11-03
ES2347754B1 ES2347754B1 (en) 2011-09-29
ES2347754B8 true ES2347754B8 (en) 2012-06-04

Family

ID=42983234

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200901093A Expired - Fee Related ES2347754B8 (en) 2009-04-27 2009-04-27 ORAL SUSPENSION OF IBUPROPHENE LISINATE

Country Status (1)

Country Link
ES (1) ES2347754B8 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2775648A1 (en) * 2018-04-06 2020-07-27 Mmc Int Health Holding S L Pharmaceutical composition in the form of an oral solution of ibuprofen salt with lysine (Machine-translation by Google Translate, not legally binding)
WO2021105524A1 (en) * 2019-11-25 2021-06-03 Mmc International Health Holding, S.L. Pharmaceutical composition of ibuprofen salt with lysine in the form of an oral solution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8813682D0 (en) * 1988-06-09 1988-07-13 Reckitt & Colmann Prod Ltd Pharmaceutical compositions
IT1243342B (en) * 1990-07-13 1994-06-10 Farcon Ag ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
IT1264857B1 (en) * 1993-06-21 1996-10-17 Zambon Spa LIQUID PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING 2- (4-ISOBUTYLPHENYL) PROPIONIC ACID
JP2003104881A (en) * 2001-09-28 2003-04-09 Taiho Yakuhin Kogyo Kk Suspension for internal application

Also Published As

Publication number Publication date
ES2347754B1 (en) 2011-09-29
ES2347754A1 (en) 2010-11-03

Similar Documents

Publication Publication Date Title
CY2018030I2 (en) PHARMACEUTICAL FORM 514
BRPI1012004A2 (en) "pharmaceutical form"
BRPI0920082A2 (en) oral dosage form of extended release acetaminophen / tramadol.
BRPI0918652A2 (en) Pharmaceutical compositions and related release methods.
ZA201003688B (en) Arginine salts and their uses for thr treatment of illnesses in the oral cavity
DK2420223T3 (en) Aqueous pharmaceutical compositions with borate-polyol complexes
BRPI0906055A2 (en) "resealable packaging"
FR2960232B1 (en) ALVEOLAR BOMBING SHAPE
SMT201400053B (en) Oral pharmaceutical forms of bendamustine
BRPI0912161A2 (en) pharmaceutical composition in the form of a tablet
PL2379086T3 (en) Pharmaceutical preparation
BRPI1014821A2 (en) "hiv replication inhibitors"
DK2391351T3 (en) Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives
GB0815972D0 (en) Pharmaceutical preparation
EP2361907A4 (en) The five crystal forms of the nicousamide, the preparation methods, the pharmaceutical compositions and the uses thereof
EP2343059A4 (en) Oral preparation
ES2347754B8 (en) ORAL SUSPENSION OF IBUPROPHENE LISINATE
BRPI1007678A2 (en) oral ingestion form and use of cationic hydroxyethylcellulose
BRPI1013935A2 (en) oral composition
LT2253329T (en) Ibuprofen lysinate oral suspension
TH91351B (en) Saliva tube
BRPI0906346A2 (en) "extended release pharmaceutical composition"
TH93628B (en) Saliva tube
TH91011B (en) bottle
NO20085206L (en) Process for the preparation of a manganese alloy

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20101103

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2347754

Country of ref document: ES

Kind code of ref document: B1

Effective date: 20110929

FD2A Announcement of lapse in spain

Effective date: 20210928